Results 101 to 110 of about 25,421 (225)
Veterinary Ophthalmology, Volume 29, Issue 4, July 2026.ABSTRACT Objective Describe the clinical features, disease progression, and outcomes of presumed primary lens instability (PLI) in cats, and to assess its association with glaucoma. Animals Studied Thirty‐four cats (68 eyes). Procedures Medical records were reviewed for signalment, clinical history, ophthalmic findings, and treatment.
Havi Sarfaty +5 more
wiley +1 more source
Comparative pharmacokinetics of intravenous ofloxacin and ciprofloxacin
, 1988 In ten volunteers the pharmacokinetics of ofloxacin and ciprofloxacin were determined after crossover administration of 100 and 200 mg intravenously (30 min constant infusion). Concentrations in serum and urine were measured by HPLC.
B. Sievers +5 more
core
, 2013 Ofloxacin concentrations in PBS and serum were respectively 140 and 212 µmom/L (51 and 76 mg/L). Serum had a high intrinsic autofluorescence at 340 nm.
Cédric Jacqueline (240373) +6 more
core +1 more source
Ofloxacin induced hypersensitivity reaction
, 2017 Ofloxacin is a commonly used antimicrobial agent to combat various infections. The adverse profile of quinolones includes gastrointestinal symptoms, which are the most frequent, neuropsychiatric symptoms, hematologic abnormalities are less common.
Suryadevara, Vidyadahara +3 more
core
Population Pharmacokinetics and Pharmacodynamics of Ofloxacin in South African Patients with Multidrug-Resistant Tuberculosis [PDF]
, 2020 g Despite the important role of fluoroquinolones and the predominant use of ofloxacin for treating multidrug-resistant tuberculosis in South Africa, there are limited data on ofloxacin pharmacokinetics in patients with multidrug-resistant tuberculosis ...
core
Population pharmacokinetics and pharmacodynamics of Ofloxacin in South African patients with multidrug-resistant tuberculosis. [PDF]
, 2012 Despite the important role of fluoroquinolones and the predominant use of ofloxacin for treating multidrug-resistant tuberculosis in South Africa, there are limited data on ofloxacin pharmacokinetics in patients with multidrug-resistant tuberculosis, no ...
Moodley, Prashini. +9 more
core +1 more source
ChemNanoMat, Volume 12, Issue 6, June 2026.This review highlights recent advances in ZnO nanocrystals, including fabrication methods, characterization techniques, and their emerging photocatalytic and biomedical applications, while discussing current challenges and future research opportunities.
Amir Zada, Shohreh Azizi
wiley +1 more source
Enantioselective Recognition Mechanism of Ofloxacin via Cu(II)-Modulated DNA
, 2016 The specific interactions of Cu2+ with self-complementary DNA sequences involving d[G4C4(GC)2G4C4], d[(GC)10], and d[(AT)10], as well as the chiral recognition mechanism of ofloxacin enantiomers via the CuII-modulated DNAs, were investigated using ...
Xiongfei Chen (356279) +3 more
core +1 more source
Brazilian Journal of Infectious DiseasesOBJECTIVE: The study aimed to investigate gyrA and gyrB mutations in Mycobacterium tuberculosis (MTB) clinical strains from 93 patients with pulmonary tuberculosis in Hubei Province, China, and analyze the association between mutation patterns of the ...
Jun Chen +8 more
doaj +1 more source
MicrobiologyOpen, Volume 15, Issue 3, June 2026.Nanobiotics offer a promising strategy to combat antimicrobial resistance (AMR) and multidrug‐resistant (MDR) bacteria. Nanoparticles overcome traditional resistance mechanisms through unique physicochemical properties and multivalent interactions.
Akmal Zubair +3 more
wiley +1 more source